Tech Company Financing Transactions
General Proximity Funding Round
General Proximity, based in San Francisco, received $9 million from Cancer Prevention and Research Institute of Texas (CPRIT).
Transaction Overview
Company Name
Announced On
11/20/2026
Transaction Type
Debt
Amount
$9,000,000
Round
Undisclosed
Proceeds Purpose
This award will help us move our lead program generated by OmniTAC into the clinic.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
135 Mississippi Street
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We've assembled a world-class team of proximity scientists from Scripps, the Broad Institute, Harvard, MIT, Yale, Oxford, and UCSF, with industry experience across top pharma and biotech institutions such as Lilly, Novartis, AbbVie, Bristol Myers Squibb, Amgen, Genentech, Roche, Alnylam, and Arvinas.
Management Team
Browse more venture capital transactions:
Prev: 11/20/2026: SCRYPT venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








